导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -15.61% | 931/1050 |
| 近一周 | -1.83% | 663/1104 |
| 近一月 | -9.39% | 1045/1103 |
| 近一季 | -21.91% | 1004/1092 |
| 近半年 | -24.45% | 1035/1070 |
| 近一年 | -4.39% | 649/1018 |
| 近两年 | 59.82% | 442/926 |
| 近三年 | 20.58% | 492/834 |
| 成立以来 | 106.34% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
5.29% 135/1070 |
0.08% 699/1101 |
- - |
- - |
| 2025 | 53.50% 160/1065 |
1.21% 707/1014 |
0.22% 666/1038 |
46.47% 116/1050 |
3.32% 231/1065 |
| 2024 | 2.91% 502/1011 |
-2.77% 463/960 |
-7.00% 747/983 |
16.97% 138/991 |
-2.70% 512/1011 |
| 2023 | -30.42% 811/952 |
-5.36% 803/880 |
-4.94% 517/895 |
-14.05% 748/915 |
-10.02% 860/952 |
| 2022 | -25.71% 520/867 |
-16.35% 318/773 |
14.92% 122/806 |
-16.75% 669/845 |
-7.16% 707/867 |
| 2021 | 45.41% 21/740 |
-8.15% 452/580 |
38.13% 18/659 |
15.83% 32/704 |
-1.05% 484/740 |
| 2020 | 88.90% 60/554 |
-7.64% 348/419 |
28.80% 142/466 |
16.83% 112/517 |
35.93% 22/554 |
| 2019 | 22.83% 326/410 |
22.30% 852/1149 |
-9.46% 1005/1231 |
2.06% 276/390 |
8.68% 211/410 |
| 2018 | -30.10% 216/349 |
- - |
- - |
- - |
-3.06% 38/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 银华新能源新材料C VS. 东吴新产业精选股票A(580008) |